Check out your Company Bowl for anonymous work chats.
Benchling is on Y Combinator's Top Companies of 2024! I’m proud to be part of #TeamScience — and even prouder to help scientists deliver their world-changing breakthroughs, faster. Join us. We’re #hiring!
“Many candidates today want to know they’ll make a difference in the world. They can find that here,” says Benchling's Dean Talanehzar. We're thrilled to be Built In San Francisco's featured company of the month. Learn more about our mission, company culture, and open roles:https: //lnkd.in/gqd2VJfu
Want to know how #biopharma is using technology to get ahead? The data has been a bit of a black box. Until now... Introducing the inaugural 2023 State of Tech in Biopharma 📊 📈 🎉 We looked at how 300 biopharma R&D and IT execs are adopting enabling tech. What did we discover? Adoption of enabling tech is high, but the environment is complex: 🔍 84% of respondents use some custom-built software 🔍 40% of IT at larger orgs manage 20+ unique scientific software applications 🔍 59% regularly use #AI/ML, despite it being relatively new tech 🔍 FAIR adoption lags, less than 1/3 achieve org-wide interoperability or reusability 🔍 IT broadly rates investment in enabling tech as more important, compared to R&D counterparts 👉🏼 Get the full story: https://www.benchling.com/state-of-tech
We just wrapped our #Benchtalk23 annual customer conference in Boston. The event was a reminder that this is THE community for science + tech 🧬 🌐 💫 with so much energy and innovation on display. The most exciting talks were from our customers: 💊 Moderna, Genentech, Cue Biopharma on big changes in process development ⚡ Generate Biomedicines, Sanofi, Dyno Tx AI/ML data best practices 💻 Genentech and Editas Medicine on open APIs and integrations 📊 ElevateBio and Aera Tx leading data and ML strategies 🌐 Lyell Immunopharma and Century Tx on user + IT-approved data strategy 💻 ArsenalBio and Dragonfly Tx's software for emerging biotech 🧪 Twist Bioscience’s automated antibody and oligo production ❤️ Verve’s one-shot cure for heart disease 🗻 Google Ventures on the scaling power of tech + bio Benchling announcements included: ⭐ Benchling Connect ⭐ Benchling Bioprocess ⭐ LLMs in Benchling (sneak preview) 👥 New Benchling Community 👉🏽 Check out all the new products: https://www.benchling.com/whats-new 👉🏽 Next up: Join us for #Benchtalk23 Europe in London, Oct 24-25, register here: https://benchtalk.benchling.com/emea
Benchling CEO and co-founder Sajith Wickramasekara goes on Bloomberg News to discuss the state of tech adoption in #biopharma, the latest products from Benchling, and science + #AI. “Biopharma is an industry that hasn’t really seen the benefits of digital transformation yet. But it’s the industry that needs it the most.” 🧬⚡🧪
“Developers who only focus on clinical efficacy and safety endpoints may find themselves in a dead end when they try to launch commercially.” This insightful Q&A from Jason C. Foster, founder of Ori Biotech, and Bob Burke, Benchling’s GM of EMEA, offers great perspective on the state of tech in UK life sciences and the catalysts for change. #biotech
Benchling is one of Built In San Francisco’s top companies to watch this summer! Find out what it’s like to be part of our team and explore our open roles. #NowHiring
We are proud to work at a company that recognizes the importance of inclusion and connection. Hear directly from Benchlings on the power of community in the workplace.
Benchling customers are creating groundbreaking solutions to improve our lives and the planet. Meet EvodiaBio: They’re reinventing the production of natural aromas for a more sustainable world, starting with beer. #BuiltOnBenchling
Better data + better analysis = better science. Now introducing Benchling product integrations with leading scientific analytics solutions like JMP.
